CareFusion Given New $50.00 Price Target at Raymond James (CFN)
Equities research analysts at Raymond James boosted their price target on shares of CareFusion (NYSE:CFN) from $48.00 to $50.00 in a research note issued to investors on Monday. Raymond James’ target price would indicate a potential upside of 16.93% from the stock’s previous close.
In other CareFusion news, Insider Thomas Leonard sold 1,250 shares of the company’s stock on the open market in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $39.06, for a total transaction of $48,825.00. Following the sale, the insider now directly owns 34,553 shares of the company’s stock, valued at approximately $1,349,640. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a “neutral” rating on shares of CareFusion in a research note on Wednesday, May 7th. They now have a $41.00 price target on the stock. Separately, analysts at Barclays cut their price target on shares of CareFusion from $44.00 to $42.00 in a research note on Tuesday, May 6th. They now have an “equal weight” rating on the stock. Finally, analysts at B. Riley cut their price target on shares of CareFusion to $39.00 in a research note on Tuesday, May 6th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. CareFusion presently has a consensus rating of “Buy” and an average price target of $42.30.
CareFusion (NYSE:CFN) remained flat at $42.76 during during mid-day trading trading on Monday. 390,876 shares of the company’s stock traded hands. CareFusion has a 1-year low of $33.70 and a 1-year high of $43.13. The stock has a 50-day moving average of $39.63 and a 200-day moving average of $39.84. The company has a market cap of $8.865 billion and a P/E ratio of 23.91.
CareFusion (NYSE:CFN) last announced its earnings results on Monday, May 5th. The company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.62 by $0.02. The company had revenue of $968.00 million for the quarter, compared to the consensus estimate of $986.67 million. During the same quarter in the previous year, the company posted $0.59 earnings per share. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. Analysts expect that CareFusion will post $2.31 EPS for the current fiscal year.
CareFusion Corporation (NYSE:CFN) is a global medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.